Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Health Canada approves SPRYCEL as first-line treatment for life-threatening blood cancer

Health Canada approves SPRYCEL as first-line treatment for life-threatening blood cancer

First genome-wide mapping of DNA modification in embryonic stem cells

First genome-wide mapping of DNA modification in embryonic stem cells

Leading cancer specialists and researchers establish Australia’s first comprehensive ‘Cancer Survivors Centre’

Leading cancer specialists and researchers establish Australia’s first comprehensive ‘Cancer Survivors Centre’

Taller women more prone to cancer: Study

Taller women more prone to cancer: Study

BioSante announces worldwide license of Melanoma Vaccine to Hussman Foundation

BioSante announces worldwide license of Melanoma Vaccine to Hussman Foundation

New strategy for improving development of induced pluripotent stem cells

New strategy for improving development of induced pluripotent stem cells

New anti-cancer drugs plus chemo for breast cancer shows promise: Study

New anti-cancer drugs plus chemo for breast cancer shows promise: Study

Cord Blood Bank of Arkansas opens at UAMS

Cord Blood Bank of Arkansas opens at UAMS

Medco announces new offerings within Advanced Oncology Solutions

Medco announces new offerings within Advanced Oncology Solutions

Chemotherapy combined with anti-cancer agent shows promise for treatment of aggressive breast cancers

Chemotherapy combined with anti-cancer agent shows promise for treatment of aggressive breast cancers

Two key genes may help prevent childhood leukemia

Two key genes may help prevent childhood leukemia

Johnson & Johnson second quarter sales increase 8.3% to $16.6 billion

Johnson & Johnson second quarter sales increase 8.3% to $16.6 billion

Anti-malaria drug provides key insight into potential treatments for autoimmune diseases

Anti-malaria drug provides key insight into potential treatments for autoimmune diseases

Coal seam gas and cancer risk: Report

Coal seam gas and cancer risk: Report

LLS awards new SCOR grants valued at $12.5M for research in lymphoma and myeloproliferative neoplasms

LLS awards new SCOR grants valued at $12.5M for research in lymphoma and myeloproliferative neoplasms

Study: IL-2 monotherapy not effective as maintenance therapy for acute myeloid leukemia

Study: IL-2 monotherapy not effective as maintenance therapy for acute myeloid leukemia

Study: Bone marrow transplant offers new hope for patients with high-risk leukemia

Study: Bone marrow transplant offers new hope for patients with high-risk leukemia

Seattle Children's inaugurates new center for cancer research

Seattle Children's inaugurates new center for cancer research

BioMarin commences BMN 673 Phase 1 trial in hematological malignancies

BioMarin commences BMN 673 Phase 1 trial in hematological malignancies

DVS Sciences completes $14.6M series A financing

DVS Sciences completes $14.6M series A financing

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.